Jerome Winegarden: ASH Continues to Show Exceptional Leadership by Advocating for Patients With Blood Diseases
Jerome Winegarden, Attending Physician and Hematology Oncology Fellowship Program Director at Trinity Health, reposted from American Society of Hematology on LinkedIn:
”ASH continues to show exceptional leadership by advocating for patients with blood diseases.
Standing up for science is not just a great tag line!
It really means something to the millions of people who suffer from blood cancers and blood related diseases.
I’m so proud to be an ASH member.”
Quoting American Society of Hematology‘s post:
”Boldly Standing Up for Science.
2025 brought unprecedented political threats to scientific research, federal funding, and access to care, but hematology thrived.
Through the hashtag Fight 4 Hematology campaign, the Society stepped up to expand research funding and training opportunities, lead impassioned advocacy efforts, and amplify the voices of clinicians, researchers, and patients.
ASH is proud to serve hematologists who are dedicated to conquering blood diseases and improving the lives of patients around the world.
Thank you for being an ASH member and helping to make 2025 such a success!
View the 2025 ASH Annual Report.”
Stay updated with Hemostasis Today.
-
Jun 27, 2026, 00:48Zain Khalpey: Why High quality CPR is Only Part of Successful Cardiac Arrest Management
-
Jun 26, 2026, 22:31Wendy Dusenbury: The New Issue of the Stroke Clinician is Now Live
-
Jun 26, 2026, 20:42Ed Watson: When It Happens to You, Stroke Becomes Personal, Immediate, and Life-Changing
-
Jun 26, 2026, 19:45Nathan Connell: Transforming Surgical Care with Tranexamic Acid
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders